Protal

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Protal

Property Description
Active ingredient Enalapril Maleate and Hydrochlorothiazide (HCTZ)
Form Fixed-Dose Combination (FDC) Tablet
Pharmacological class ACE Inhibitor / Thiazide Diuretic Combination
Common use Management of High Blood Pressure (Hypertension)
Origin Synthetic Pharmaceutical Compound

Protal is a synthetic, prescription-only antihypertensive agent formulated as a fixed-dose combination (FDC) tablet for oral administration. The foundational identity of this medicine is rooted in its strategic dual mechanism, which is clinically recognized for enhanced efficacy in lowering blood pressure compared to treatment with a single drug component. It is broadly utilized to provide comprehensive management for adult patients with essential hypertension.

What Type of Medicine is Protal?

Protal belongs to the pharmacological class of Angiotensin-Converting Enzyme (ACE) Inhibitor / Thiazide Diuretic combinations, placing it among established therapeutic options for systemic blood pressure management. This dual classification confirms its use of two distinct actions: one modulating the neurohormonal system and another promoting fluid and salt excretion. This combined strategy is designed for patients who require the benefit of both an ACE Inhibitor and a diuretic to achieve blood pressure goals.

Composition: Enalapril Maleate and Hydrochlorothiazide (HCTZ)

The core composition of Protal involves the two active ingredients: Enalapril Maleate and Hydrochlorothiazide (HCTZ). This two-component formulation is an established product. Enalapril Maleate serves as the ACE Inhibitor component, which helps the blood vessels relax, while Hydrochlorothiazide acts as the Thiazide Diuretic, facilitating the removal of excess salt and water. This strategic combination ensures simultaneous action on both vascular tone and circulating fluid volume.

Purpose of the Dual-Action Antihypertensive Strategy

The primary purpose of Protal is to leverage the synergistic effect of its two agents to achieve a more comprehensive and stable reduction in blood pressure. The combined action provides a highly effective means of reducing the mechanical strain placed on the cardiovascular system. This combined regimen is a key strategy for the long-term management of hypertension.

What side effects are possible with Protal?

Possible Side Effects and Safety Information

The official safety characteristics of Protal (Enalapril Maleate and Hydrochlorothiazide) are formally classified by regulatory authorities based on the frequency and the affected body system. This section details the officially documented adverse reactions and safety restrictions.

Frequency-Classified Adverse Reactions

The most frequently reported reaction, classified as Very Common (occurring in ge1/10 patients), is Dizziness. Adverse effects classified as Common (ge1/100 to <1/10) include Headache, Cough, Fatigue (Asthenia), Nausea, and manifestations of low blood pressure, such as Hypotension and Syncope.

Less frequently reported, Rare (ge1/10,000) reactions documented in the official label include serious hematological events like Agranulocytosis and severe skin conditions such as Stevens-Johnson Syndrome (SJS).

System and Safety Constraints

Adverse reactions are grouped by System-Organ Class (SOC), including Vascular Disorders (e.g., Hypotension), Nervous System Disorders (e.g., Headache), and Metabolism and Nutrition Disorders (e.g., electrolyte imbalance).

Serious Adverse Reactions highlighted in regulatory documents include Angioedema (swelling of the face and throat) and cases of Hepatic Failure or Acute Renal Failure.

Official safety restrictions specifically note that the medication is contraindicated in pregnancy due to the high risk of fetal injury and death. Use is also restricted in patients with severe renal impairment or a history of ACE inhibitor-related Angioedema. Certain risks are time-related; for instance, the risk of Non-melanoma Skin Cancer is associated with long-term, cumulative exposure to the thiazide component.

Overdose and Emergency Response

Documented Overdose Manifestations

Overdose of Protal, a combination of an Angiotensin-Converting Enzyme (ACE) inhibitor and a thiazide diuretic, is officially documented to result primarily in manifestations related to volume and hemodynamic instability. The most likely presentation is profound hypotension (excessively low blood pressure) and symptoms such as syncope (fainting), dizziness, and lightheadedness.

Overdosage further results in clinical signs of dehydration and substantial electrolyte depletion, including laboratory findings of hypokalemia (low potassium) and hyponatremia (low sodium). In patients with renal insufficiency, the official label notes that the active component, Enalaprilat, has a prolonged half-life, which necessitates close monitoring during an overdose scenario.

Required Emergency Actions

Regulatory documents classify certain overdose scenarios as life-threatening. Severe hypotension may potentially lead to secondary events, including myocardial infarction or cerebrovascular accident. The risk of laryngeal edema is also noted as potentially fatal. Therefore, regulatory guidelines mandate that individuals seek emergency medical attention immediately for any suspected overdose.

Specific triggers for calling emergency services include the presence of collapse, a seizure, trouble breathing, or an inability to be awakened. The official management approach is strictly symptomatic and supportive treatment; no specific antidote is known for this combination. Procedural steps noted in official labeling include the administration of an intravenous saline solution to counteract hypotension and the fact that Enalaprilat is dialyzable.

Therapeutic Uses of Protal

What Protal Treats: Main Uses and Benefits

Protal is generally used for the long-term management of essential hypertension (chronic high blood pressure), addressing symptoms related to systemic imbalance, such as persistently elevated arterial pressure. The medication is primarily applied in addressing high blood pressure and is considered relevant in conditions involving recurrent or episodic manifestations. The goal of therapy may be to support stable blood pressure reduction in adult patients.

This combination therapy is applied in clinical settings that involve heightened systemic burden, particularly when supportive symptom management is appropriate due to difficult-to-control blood pressure. This type of therapy helps ease the overall symptom load by supporting protective measures against serious long-term complications.

“When supporting control of blood pressure, this type of therapy assists with maintaining functional stability and supports general well-being during symptomatic phases.”

Quick Fact: Support for Physiological Strain

This application assists with maintaining functional stability by managing symptoms related to heightened physiological activity and helps improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Protal?

The population eligibility for Protal (Enalapril Maleate and Hydrochlorothiazide) is defined by official regulatory documentation, which specifies who is permitted to use the medicine and under what conditions use is strictly prohibited or limited.

Contraindicated Populations (Must Not Use)

The medicine is absolutely contraindicated and must not be used by individuals who meet the following criteria:

  • Patients with a known hypersensitivity to Enalapril, Hydrochlorothiazide, or any other sulfonamide-derived drugs.
  • Patients with a history of angioedema (severe swelling) related to previous ACE Inhibitor therapy or who have hereditary or idiopathic angioedema.
  • Individuals with anuria (inability to pass urine).
  • Diabetic patients who are concurrently taking medications containing aliskiren.
  • Patients who have taken a medicine containing sacubitril within the last 36 hours.

Age and Physiological Restrictions

Category Regulatory Status
Pregnancy Contraindicated in the second and third trimesters. Discontinue as soon as possible if pregnancy is detected.
Lactation Should not be used; a decision must be made to discontinue nursing or the drug.
Pediatrics Not recommended; safety and efficacy have not been established in patients under 18 years of age.

Condition-Based Limitations

Use is not recommended for patients with severe renal impairment (creatinine clearance le 30 mL/ min) and caution is required in patients with severe hepatic impairment.

What should I know about interactions with other medicines?

Protal Interactions with other medicines and products

The official interaction profile for Protal is structured around its metabolic pathways and additive pharmacological effects with other medicines. A major constraint involves the co-administration of potent inhibitors of Cytochrome P450 (CYP) enzymes such as CYP1A2, CYP2D6, and CYP2C19. This combination is associated with significantly increased exposure to Protal, and therefore avoidance is required due to the potential for excessive beta-blockade. Conversely, strong inducers of these same enzymes (e.g., Rifampin) decrease Protal exposure, which may reduce its efficacy and warrants caution or avoidance.

Clinically Significant Interaction Categories

  • Calcium Channel Blockers: Co-administration of Protal with certain non-dihydropyridine calcium channel blockers (e.g., Verapamil, Diltiazem) is a documented restriction due to additive negative effects on cardiac conduction and contractility. This combination is restricted or requires strict caution.
  • Other Antihypertensives and Antiarrhythmics: Concurrent use of other medications that lower blood pressure or affect heart rhythm, such as alpha-blockers or certain antiarrhythmic drugs, presents a risk of additive pharmacodynamic effects (e.g., severe hypotension or bradycardia). Close monitoring of heart rate and blood pressure is required by labeling.
  • Antidiabetic Agents: Use with insulin or oral hypoglycemic agents may mask the common early signs of low blood sugar, such as a fast heart rate, requiring specific patient counseling and vigilance for hypoglycemia.
  • Non-steroidal Anti-inflammatory Drugs (NSAIDs): Use of NSAIDs is associated with a potential reduction in the blood pressure-lowering effect of Protal.

Mechanism of Action

Dual Modulation of Vascular Tone and Fluid Volume

The mechanism of Protal is rooted in the synergistic action of its two components, simultaneously targeting both the fluid and resistance factors governing systemic pressure. This combination modulates pathways associated with heightened physiological responses, resulting in a coordinated physiological adjustment of circulatory dynamics.

Inhibition of the Renin-Angiotensin-Aldosterone System (RAAS)

The Enalapril Maleate component acts as a competitive inhibitor of the Angiotensin-Converting Enzyme (ACE). By blocking ACE, the drug restricts the formation of the vasoconstrictor, Angiotensin II, while also reducing the degradation of the vasodilator Bradykinin. This molecular cascade results in reduced Total Peripheral Resistance (TPR) and induces vessel relaxation.

Targeted Reduction of Circulating Volume

The Hydrochlorothiazide (HCTZ) component engages a separate pathway by blocking the Na^+/ Cl^- cotransporter (NCC) in the kidney's distal convoluted tubule. This targeted interference with electrolyte reabsorption increases the renal excretion of sodium and water (natriuresis and diuresis), directly leading to a decrease in circulating plasma volume. The combination ensures that the fluid loss from HCTZ does not trigger a compensatory rise in RAAS activity, thereby limiting the counter-regulatory hormonal response.

Dosage and Administration Information

Protal is administered orally as a fixed-dose combination tablet. The medication is designed for maintenance therapy in adult patients whose blood pressure is not adequately controlled with one of the components alone; it is not suitable for initiating treatment for essential hypertension.

The standard regimen is to take one tablet once daily. However, the total daily dose may sometimes be administered in two divided doses to maintain the antihypertensive effect. The tablets may be taken with or without food and should be swallowed with sufficient fluid. The maximum daily dose generally should not exceed the 20 mg / 50 mg combined strength of enalapril and hydrochlorothiazide.

For proper use, the fixed-dose combination is not recommended in patients with severe renal impairment (creatinine clearance < 30 mL / min). In older adults, titration with enalapril alone prior to using the fixed combination is often considered due to the assessment of physiological renal function. The safety and efficacy of this combination have not been established for the pediatric population (under 18 years). If a dose is missed, the patient should not take a double dose; the regular dosing schedule should be resumed at the next scheduled time. The fixed dose tablet is bioequivalent to the concurrent administration of the two individual components.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research on Efficacy

Research has explored whether Protal may be associated with a reduction in the severity of chronic pain. Studies have evaluated whether combining this therapy with standard treatment may be associated with changes in patient-reported quality of life.

  • Dose-Finding Trials: Initial studies focused on identifying optimal dosing schedules and assessing short-term effects on symptoms. Findings were mixed on immediate symptom relief across all dose groups, and further research is underway.
  • Long-Term Observational Studies: Some studies investigated the frequency of flare-ups observed during the treatment period. This research also examined the overall profile of extended use.

Safety Profile and Tolerability

Trials have investigated how the compound interacts with the body. The safety profile was assessed in most adult patients; however, studies excluded participants with severe kidney impairment as part of the trial design.

  • Adverse Event Data: The trials documented that headache and fatigue were among the most frequently observed events. Study records note that some participants ceased taking the compound due to reported gastrointestinal discomfort.
  • Administration Timing: Trials assessed administration timing and recorded patient outcomes. Researchers have not yet reached a conclusion regarding the influence of administration timing on long-term outcomes.

Special Populations and Comparisons

Some studies evaluated whether the drug was associated with the long-term complication rate in high-risk individuals. Evidence remains limited on the effects in pediatric populations, as these groups were generally excluded from initial phase trials.

  • Comparative Effectiveness: A recent meta-analysis compared this therapy to older therapies. The findings reported in the analysis are being considered in further investigation regarding potential differences in long-term symptom management.

Key Studies & References Clinical Guideline for the Treatment of Chronic Inflammatory Conditions: Specific Recommendations for Biologics and Novel Agents (e.g., Protal)

Frequently Asked Questions (FAQ)

Common questions about Protal (FAQ)


Q: How quickly does Protal usually start working?

According to the official product information, an initial reduction in blood pressure may be observed within one to two hours after taking a dose. However, the maximum intended blood pressure-lowering effect typically requires approximately three to four weeks of consistent use as described in the official dosing regimen.


Q: Are there common mental health effects associated with Protal use?

Regulatory documents indicate that adverse effects related to the nervous and psychiatric systems have been reported with Protal. These effects, which have been observed in studies, may include feelings of nervousness or depressed mood. Regulatory sources advise consultation with a healthcare professional regarding adverse events.


Q: Can I stop taking Protal suddenly?

The sudden discontinuation of Protal is generally a topic of regulatory caution. Official documents caution that the sudden cessation of the medicine has been associated with the potential for a rapid rise in blood pressure.


Q: Can older adults use Protal?

Regulatory documents indicate that when considering Protal for older adults, caution is described as necessary. Official documents suggest that, in some cases, a healthcare professional may first recommend treatment with the individual components separately before the fixed-dose combination is used.


Q: Is Protal the same type of medicine as [similar drug name]?

Protal is defined in official labeling as a fixed-dose combination that belongs to the pharmacological class of Angiotensin-Converting Enzyme (ACE) Inhibitor and Thiazide Diuretic combination medicines. This classification is used to define its dual mechanism of action for managing high blood pressure.


Q: Is it normal to feel [mild, non-serious symptom] when first taking Protal?

Official information documents acknowledge that when starting Protal, some common adverse events have been reported. These frequently reported events can include dizziness, headache, and a feeling of fatigue.


Q: Does Protal interact with common over-the-counter pain relievers?

Regulatory documents advise that the blood pressure-lowering effect of Protal may be reduced if it is taken at the same time as Non-steroidal Anti-inflammatory Drugs (NSAIDs). This finding is based on studies of drug interactions described in the official label.


Q: Is Protal safe for people who have kidney issues?

Official product information places restrictions on the use of Protal in individuals with severe renal impairment (creatinine clearance le 30 mL/ min). The drug is not recommended for this specific, severely limited population.


Q: What is the difference between Protal and a supplement?

Protal is classified as a synthetic, prescription-only antihypertensive agent. This means it has undergone formal regulatory review and approval by government health authorities for a specific medical indication, distinguishing it from dietary supplements.


Q: Does Protal cause weight changes?

Official product documentation reports that weight changes, including both increases and decreases, have been observed as adverse events in clinical study settings. These effects are classified under Metabolism and Nutrition Disorders.


Q: Are there any specific foods or drinks to avoid while on Protal?

Regulatory documents advise exercising caution with alcohol consumption, as it may increase the drug's blood pressure-lowering effects. Additionally, the use of potassium-containing salt substitutes is a specific dietary constraint described in the regulatory documents.


Q: Will Protal affect my ability to drive or operate machinery?

Official labeling includes a warning regarding the potential for impairment. Since Protal can cause common adverse reactions like dizziness or fatigue, these effects may influence a person’s ability to drive or safely operate heavy machinery.


Q: What kind of label warnings are usually associated with Protal?

The most serious warnings highlighted in regulatory documents relate to the risks of fetal toxicity if the drug is used during pregnancy, and the potential for angioedema (severe swelling of the face, throat, and limbs) due to the ACE inhibitor component.


Q: What is the typical duration of effect for a dose of Protal?

The typical duration of effect is inferred from the standard dosing regimen. Protal is generally prescribed to be taken once daily, which indicates that the intended therapeutic effect for blood pressure management lasts for a 24-hour period.


Q: Does Protal affect sleep patterns?

Official documentation reports that some users have experienced insomnia, or difficulty sleeping, as a documented adverse reaction to Protal.


Q: Can I take Protal if I have a history of liver problems?

Official documents state that regulatory authorities require caution when the medicine is used in patients with a history of liver issues. Use is generally not recommended for individuals with severe hepatic (liver) impairment.

How should Protal be stored and disposed of?

How to Store and Dispose of Protal?

The storage and disposal of Protal (Enalapril Maleate and Hydrochlorothiazide) tablets are strictly governed by regulatory requirements to ensure product integrity and public safety.

Storage Requirements

The medication must be stored at Controlled Room Temperature, specifically 20 C to 25 C (68 F to 77 F). The product must be protected from freezing, excess heat, and moisture. It is required to keep the tablets in the container they came in, with the lid tightly closed.

Disposal and Safety

To prevent accidental exposure, Protal must be stored out of the sight and reach of children. Unused or expired tablets should be disposed of by utilizing an authorized drug take-back program. If a take-back option is unavailable, the medication should be mixed with an unappealing substance, sealed in a bag, and then discarded in the household trash, following official guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Protal found in:

A-Z Index: